Hyperfine, Inc. — Director's Dealing 2022

Nov 1, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Hyperfine, Inc. (HYPR)
CIK: 0001833769
Period of Report: 2022-10-31

Reporting Person: Siddiqui Khan (CMO and Chief Strategy Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-10-31	Stock Option (right to buy)	$3.76	D	235145	Disposed	2030-01-27	Class A Common Stock (235145)	Direct
2022-10-31	Stock Option (right to buy)	$0.91	A	235145	Acquired	2030-01-27	Class A Common Stock (235145)	Direct
2022-10-31	Stock Option (right to buy)	$3.27	D	54037	Disposed	2031-04-14	Class A Common Stock (54037)	Direct
2022-10-31	Stock Option (right to buy)	$0.91	A	54037	Acquired	2031-04-14	Class A Common Stock (54037)	Direct
2022-10-31	Stock Option (right to buy)	$5.24	D	1796	Disposed	2031-05-12	Class A Common Stock (1796)	Direct
2022-10-31	Stock Option (right to buy)	$0.91	A	1796	Acquired	2031-05-12	Class A Common Stock (1796)	Direct
2022-10-31	Stock Option (right to buy)	$3.90	D	110000	Disposed	2032-02-09	Class A Common Stock (110000)	Direct
2022-10-31	Stock Option (right to buy)	$0.91	A	110000	Acquired	2032-02-09	Class A Common Stock (110000)	Direct
2022-10-31	Stock Option (right to buy)	$3.90	D	74000	Disposed	2032-02-09	Class A Common Stock (74000)	Direct
2022-10-31	Stock Option (right to buy)	$0.91	A	74000	Acquired	2032-02-09	Class A Common Stock (74000)	Direct

Footnotes

F1: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021, of which 161,657 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Siddiqui's continued service on each vesting date.

F2: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021, of which 23,646 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Siddiqui's continued service on each vesting date.

F3: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021, of whlich 636 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Siddiqui's continued service on each vesting date.

F4: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on February 9, 2022, of which 45,833 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Siddiqui's continued service on each vesting date.

F5: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The shares underlying this option vest as to 25% on February 9, 2023, and 2.083% at the end of each month thereafter beginning on March 31, 2023, subject to Dr. Siddiqui's continued service through the applicable vesting date.